BOLD - Company ID 0001782303
The table below shows Boundless Bio, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $17.87M | $26.59M |
| Short-term investments | $89.71M | $125.53M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $109.61M | $154.39M |
| Property, plant & equipment | $3.22M | $4.32M |
| Goodwill | - | - |
| Total assets | $157.06M | $206.41M |
| Accounts payable | $1.49M | $1.27M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $12.54M |
| $8.13M |
| Long-term debt | - | - |
| Total liabilities | $58.41M | $55.77M |
| Retained earnings | -$259.67M | -$201.47M |
| Total equity | $98.65M | $150.64M |